Weyoon

I got my 2 accounts back from being suspended @/yoonlovesol and @/yoon2lovesol but both are now GB. So I decided not to use both and lock it now. This is my only account now that I'll be using for joining giveaways hihi @yoonwewin thank you so much!

@ClassyBeef Thanks ClassyBeef. I'm following both providers. 🆔 Legendalia

Thank you so muchieeeee sa blessing @AliaxxVesper labyuuu ate! More more more more more great things pa for youuuuu

Solana for the win! Fast transactions, low fees, and one of the strongest ecosystems in crypto right now. Also love that you can easily get $SOL through @RampNetwork 👀

@gibdotmeme thank you @gibdotmeme for the chance!! - made an account ✅ - notifs on ✅ - dropped my usn 👇✅ usn: marcies let me run it up pk @gibdotmeme 😗❤️

20 ~ 6 hours (0526X06) 🪹🍩🎣🚎 R | F : x.com/SlideFunBot - - - - - “Strength is staying kind in a world that hardens people.” 🤍

10 ~ 2 hours (0526X07) 🌅💪🧠✨ R | F : x.com/zazzkeee - - - - - “I face each new day with confidence, courage, and clarity.”

Waiting for 14 hours. 🥶

@MarkoooPicks Wowwwww

SDM cutie pls

@RealFish thank you @RealFish! following you with notifications on, and always active on your regular posts 🫡🩷 manifesting this dub champ

can't wait to grind kay juicy

@AliaxxVesper Congrats ate

Na-wi-withdraw din sa wakas.

@qwibill @ValkyrieXStudio @ProdigyDDK Wowwww you keep winning! Congrats. To more more more winssss @ValkyrieXStudio @ProdigyDDK should see this

Never fadeee u @ValkyrieXStudio @ProdigyDDK 😔🫶

@YeoAKRewards Thank you so much fammm! 99vVAq2Y18pWV8YLkcixb5vNmedaHgLAm3pDrimRLdhm

$10 giveaway | You have 67 minutes… 🟣 Follow + Like + RT 🟣 Drop Solana addy How long till we hit 1k followers?

@liylotte Hellooooo @liylotte 👋

toktok,annyeonghaseyo! Can you spare me some of your time? Please kindly mention my username. Thank you so much,arigatosingkamas 😚

Summit Therapeutics ($SMMT) completely disrupted the lung cancer space by showing ivonescimab could best Keytruda in early trials. But with massive volatility around recent survival data, competing data readouts at ASCO, and Wall Street deeply divided on whether early progression-free survival (PFS) advantages will actually translate to global overall survival (OS), the data is incredibly noisy for investors to parse. Question: When tracking highly watched, single-asset oncology narratives like Summit’s ivonescimab, how does Lucent’s AI model synthesize disparate global regulatory signals, trial-site enrollment data, and cross-trial comparator metrics to map out true clinical probability of success before a definitive OS readout drops? Hope this one gets answered, thank you @ax1vc & @UseLucentHQ! 🙌🏻

@MarkoooPicks @xaliora Congratsss pooooo

🚨 WINNER ALERT 🚨 Congratulations @xaliora for winning $20 USDT from the raffle. 🌐 markopicks.com